Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
MAGHREB Pharma ExpoMAGHREB Pharma Expo
Not Confirmed
Not Confirmed
21-23 April, 2026
Not Confirmed
Not Confirmed
21-23 April, 2026
Not Confirmed
Not Confirmed
21-23 April, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
MAGHREB Pharma ExpoMAGHREB Pharma Expo
Industry Trade Show
Not Confirmed
21-23 April, 2026
Industry Trade Show
Not Confirmed
21-23 April, 2026
Industry Trade Show
Not Confirmed
21-23 April, 2026
Digital content

12 Apr 2017
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-12-2017-1491972590.pdf
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Through the acquisition, Bora will utilize Almatica's generic pharmaceutical products, including Zestril (lisinopril), an oral tablet used for treating hypertension, for commercialization purposes.
Lead Product(s): Lisinopril
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Zestril
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: TWi Pharmaceuticals
Deal Size: $38.5 million Upfront Cash: Undisclosed
Deal Type: Acquisition August 18, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Lisinopril
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : TWi Pharmaceuticals
Deal Size : $38.5 million
Deal Type : Acquisition
Bora Acquires Six US Brand Product Licenses, Rights
Details : Through the acquisition, Bora will utilize Almatica's generic pharmaceutical products, including Zestril (lisinopril), an oral tablet used for treating hypertension, for commercialization purposes.
Product Name : Zestril
Product Type : Miscellaneous
Upfront Cash : Undisclosed
August 18, 2023

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
ALMATICA PHARMA INC is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of Naproxen bulk with DMF offered by ALMATICA PHARMA INC
Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN WALDRICK, NEW JERSEY. bulk offered by ALMATICA PHARMA INC
Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN DEESIDE, UNITED KINGDOM. bulk offered by ALMATICA PHARMA INC